Recombinant antibodies and recombinant proteins: Prolonged-action drugs
- 作者: Gabibov A.G.1
-
隶属关系:
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry
- 期: 卷 86, 编号 3 (2016)
- 页面: 169-173
- 栏目: Scientific Session of the General Meeting of the Russian Academy of Sciences
- URL: https://journals.rcsi.science/1019-3316/article/view/178692
- DOI: https://doi.org/10.1134/S1019331616030114
- ID: 178692
如何引用文章
详细
An intensively developing trend in modern biotechnology is the production of recombinant antibodies and proteins. Recombinant antibodies have immunogenic properties and can stay in the blood for a long time; neutralize pathogens, toxins, and viruses; and destroy tumor cells. Recombinant proteins are widely used to cure, prevent, and diagnose diseases. A topical trend in modern medical biotechnology is the creation of prolonged-action drugs based on proteins obtained by genetic engineering methods. The issue of improving the specificity and selectivity of preparations based on enzymes and antibodies awaits solution. All this can be implemented using the approaches of modern combinatorial chemistry and biology, as well as quantum-mechanical calculations.
作者简介
A. Gabibov
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry
编辑信件的主要联系方式.
Email: gabibov@gmail.com
俄罗斯联邦, Moscow
补充文件
